---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-23-003881"
form_type: "8-K"
ticker: "NXL"
cik: "0001527352"
company_name: "Nexalin Technology, Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:10:23.089119+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nexalin forms JV with Wider Come to commercialize tACS devices in Asia; Wider funds ops and 4 trials

## Summary
- JV ownership: Wider 52%, Nexalin 48%; will market Gen-2 tACS devices in China and Asia Pacific.
- Wider to fund all JV operating expenses for 12 months, then pro rata funding.
- Wider obligated to fund and conduct four clinical trials (insomnia, depression, other) using Gen-2 devices.
- Previously Wider was an authorized distributor; role now expanded to include clinical development.
- NMPA approval for insomnia and depression already in place for tACS device.

## SEC filing metadata
- accession: 0001829126-23-003881
- form_type: 8-K
- ticker: NXL
- cik: 0001527352
- company_name: Nexalin Technology, Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527352/000182912623003881/0001829126-23-003881-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527352/000182912623003881/nexalin_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-23-003881
- JSON: https://secwatch.observer/filing/0001829126-23-003881.json
- Plain text: https://secwatch.observer/filing/0001829126-23-003881.txt

## Key facts
- Material Agreements
  Nexalin Technology, Inc. entered into Joint Venture Agreement with Wider Come Limited (effective 2023-05-31).
  - Action: entry
  - Agreement: collaboration
  - Counterparty: Wider Come Limited
  - Effective: 2023-05-31
  source text: On May 31, 2023, Nexalin Technology, Inc. (the “Company”) formalized an agreement related to the formation of a joint venture
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527352/000182912623003881/0001829126-23-003881-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.